PAR PHARMACEUTICAL COMPANIES, INC.
DelistedCIK 878088fmd_08MCHY5S1HN0WFT8V3WXR0N0PTManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2015, 21 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2013 |
|---|---|---|---|---|
| Total revenues | 1,193 | 1,009 | 926 | – |
| Cost of revenue | 859 | 635 | 539 | – |
| Gross profit | 334 | 374 | 387 | – |
| Research and development | 39 | 50 | 47 | – |
| Selling, general and administrative | 165 | 193 | 173 | – |
| Total operating expenses | 206 | 247 | 437 | – |
| Operating income | 131 | 133 | (51) | – |
| Interest expense | 8 | 3 | 3 | – |
| Interest and investment income | 3 | 1 | 1 | – |
| Income before taxes | 126 | 135 | (52) | – |
| Income tax expense | 49 | 42 | (6) | – |
| Net income from continuing operations | 78 | 93 | (46) | – |
| Net income | 77 | 93 | (26) | (106) |